Join to View Full Profile
203 Cox BlvdGoldsboro, NC 27534
Phone+1 919-580-0000
Fax+1 919-580-0209
Dr. Kasbari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 2001 - 2004
St. George's University School of MedicineClass of 2001
Certifications & Licensure
NC State Medical License 2008 - 2026
CT State Medical License 2004 - 2006
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Start of enrollment: 2011 Apr 07
- A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen Start of enrollment: 2014 Apr 09
Publications & Presentations
PubMed
- 3 citationsPhase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929.Nagla Abdel Karim, Jieling Miao, Karen L Reckamp, Carl M Gay, Lauren A Byers
Journal of Thoracic Oncology. 2025-03-01 - 5 citationsPhase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.Amy S Clark, Fangxin Hong, Richard S Finn, Angela M DeMichele, Edith P Mitchell
Clinical Cancer Research. 2023-04-14 - 16 citationsLongitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.Ian R. Kleckner, Todd A. Jusko, Eva Culakova, Kaitlin Chung, Amber S. Kleckner
Breast Cancer Research and Treatment. 2021-06-30
Press Mentions
OneOncology Partners with Southeastern Medical Center to Expand Cancer Care in Eastern North CarolinaOctober 21st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
